Get started
Author

Michael K. Gibson

Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma.
2026 · David Bing Zhen, Richard T. Maziarz, et al. · Journal of Clinical Oncology · 2
Spatial analysis of CD8+ T cell neighbors using multiplexed immunofluorescence (MxIF) in esophageal squamous cell carcinoma (ESCC).
2026 · Margaret Wheless, Tatsuki Koyama, et al. · Journal of Clinical Oncology
Determinants of biomarker testing and treatment selection by oncologists caring for patients (pts) with gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (AC).
2026 · Rupali Fuldeore, Michael K. Gibson, et al. · Journal of Clinical Oncology
ACCRU-GI-1810: Trifluridine/tipiracil (FTD-TPI) or paclitaxel (PAC) in combination with ramucirumab (RAM) for patients (pts) with previously treated advanced gastroesophageal adenocarcinoma (GEA)—An investigator-initiated, randomized non-inferiority phase 2 study.
2026 · Mohamad Bassam Sonbol, Angela Ulrich, et al. · Journal of Clinical Oncology
PDF
Works count: 4
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type